biomedcentral.com/bmcbiotechnol/article
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
BMC Biotechnology
official impact factor 2.35
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My BMC Biotechnology

Submit a manuscript Register Sign up for article alerts Contact us Follow us on Twitter

Explore BMC Biotechnology

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles
  • Sections
  • Most popular RSS
  • Archive
  • Supplements

Volume 12 (2012) - February 2012

next >
up
< previous

Commentary   Open Access Highly Accessed

Armed and accurate: engineering cytotoxic T cells for eradication of leukemia

Marko Radic BMC Biotechnology 2012, 12:6 (8 February 2012)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Marko Radic discusses recent advances in cancer immunotherapy, whereby cytotoxic T cells from patients with leukemia are turned into efficient and specific killers of their own cancer cells.


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.